Creative Medical Technology Holdings Inc reports results for the quarter ended in March - Earnings Summary

• Creative Medical Technology Holdings Inc CELZ reported a quarterly adjusted loss of 73 cents​​ per share for the quarter ended in March, lower than the same quarter last year, when the company reported EPS of -70 cents. The lone analyst forecast for the quarter was for a loss of $1.15 per share.

• Reported revenue was zero​; analysts expected zero.

• Creative Medical Technology Holdings Inc's reported EPS for the quarter was a loss of 73 cents​.

• The company reported a quarterly loss of $1.04 million.

• Creative Medical Technology Holdings Inc shares had fallen by 17.5% this quarter and lost 6.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.9% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• Wall Street's median 12-month price target for Creative Medical Technology Holdings Inc is $30.00

This summary was machine generated from LSEG data May 10 at 10:44 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)